Vault-13

NEXTBio Capital Management LP

AUSTIN, TX · CIK 2038158 · 13F filing filed 2026-08-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$217.4m reported value +0.9% vs Q1 2026
22positions
77.7%in top 10
3 new 7 added 5 reduced 5 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 219,333 $26.9m12.37% 12.37% ReducedShares held: Q3 2025 —, Q4 2025 229.6k, Q1 2026 229.6k, Q2 2026 219.3k -10.3k -10,286 -4.5%
2 SHATTUCK LABS INC COM STTK STTK 3,727,348 $25.9m11.90% 11.90% AddedShares held: Q3 2025 —, Q4 2025 3.1m, Q1 2026 3.1m, Q2 2026 3.7m +577.4k +577,441 18.3%
3 COMPASS PATHWAYS PLC SPONSORED ADS CMPS CMPS 1,775,759 $25.1m11.56% 11.56% ReducedShares held: Q3 2025 —, Q4 2025 752.6k, Q1 2026 2.0m, Q2 2026 1.8m -245.6k -245,648 -12.2%
4 STRUCTURE THERAPEUTICS INC SPONSORED ADS GPCR GPCR 312,496 $16.8m7.71% 7.71% AddedShares held: Q3 2025 —, Q4 2025 94.4k, Q1 2026 133.2k, Q2 2026 312.5k +179.3k +179,257 134.5%
5 VOR BIOPHARMA INC COM NEW VOR VOR 889,164 $16.4m7.53% 7.53% ReducedShares held: Q3 2025 —, Q4 2025 1,000.0k, Q1 2026 1,000.0k, Q2 2026 889.2k -110.8k -110,803 -11.1%
6 RHYTHM PHARMACEUTICALS INC COM RYTM RYTM 131,758 $14.6m6.73% 6.73% AddedShares held: Q3 2025 —, Q4 2025 67.6k, Q1 2026 126.1k, Q2 2026 131.8k +5.7k +5,680 4.5%
7 PALVELLA THERAPEUTICS INC NE COM PVLA PVLA 89,909 $13.7m6.32% 6.32% AddedShares held: Q3 2025 —, Q4 2025 82.7k, Q1 2026 82.7k, Q2 2026 89.9k +7.2k +7,223 8.7%
8 XENON PHARMACEUTICALS INC COM XENE XENE 183,225 $11.1m5.09% 5.09% UnchangedShares held: Q3 2025 —, Q4 2025 183.7k, Q1 2026 183.2k, Q2 2026 183.2k
9 ZENAS BIOPHARMA INC COM ZBIO ZBIO 426,736 $10.8m4.98% 4.98% UnchangedShares held: Q3 2025 —, Q4 2025 322.0k, Q1 2026 426.7k, Q2 2026 426.7k
10 ORIC PHARMACEUTICALS INC COM ORIC ORIC 706,124 $7.6m3.52% 3.52% AddedShares held: Q3 2025 —, Q4 2025 615.7k, Q1 2026 523.6k, Q2 2026 706.1k +182.5k +182,505 34.9%
11 INVENTIVA SA ADS IVA IVA 1,787,984 $6.8m3.11% 3.11% AddedShares held: Q3 2025 —, Q4 2025 1.3m, Q1 2026 1.3m, Q2 2026 1.8m +454.5k +454,500 34.1%
12 CRESCENT BIOPHARMA INC. COM CBIO CBIO 372,856 $6.7m3.09% 3.09% UnchangedShares held: Q3 2025 —, Q4 2025 372.9k, Q1 2026 372.9k, Q2 2026 372.9k
13 VAXCYTE INC COM PCVX PCVX 107,223 $6.2m2.87% 2.87% AddedShares held: Q3 2025 —, Q4 2025 95.5k, Q1 2026 95.2k, Q2 2026 107.2k +12.0k +12,000 12.6%
14 COGENT BIOSCIENCES INC COM COGT COGT 131,075 $5.1m2.33% 2.33% ReducedShares held: Q3 2025 —, Q4 2025 95.8k, Q1 2026 131.2k, Q2 2026 131.1k -113 -113 -0.1%
15 VERASTEM INC COM NEW VSTM VSTM 1,306,800 $5.0m2.30% 2.30% UnchangedShares held: Q3 2025 —, Q4 2025 1.3m, Q1 2026 1.3m, Q2 2026 1.3m
16 DISC MEDICINE INC COM IRON IRON 52,655 $3.9m1.77% 1.77% UnchangedShares held: Q3 2025 —, Q4 2025 42.8k, Q1 2026 52.7k, Q2 2026 52.7k
17 PHARVARIS N V COM PHVS PHVS 108,055 $3.7m1.72% 1.72% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 108.1k
18 ZAI LAB LTD ADR ZLAB ZLAB 183,362 $3.5m1.60% 1.60% UnchangedShares held: Q3 2025 —, Q4 2025 163.4k, Q1 2026 183.4k, Q2 2026 183.4k
19 BIOAGE LABS INC COM BIOA BIOA 100,732 $2.5m1.14% 1.14% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 100.7k
20 LB PHARMACEUTICALS INC COM SHS LBRX LBRX 68,249 $2.2m1.02% 1.02% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 68.2k
21 EVOMMUNE INC COM SHS EVMN EVMN 119,063 $1.6m0.73% 0.73% ReducedShares held: Q3 2025 —, Q4 2025 228.3k, Q1 2026 184.1k, Q2 2026 119.1k -65.0k -65,000 -35.3%
22 ADICET BIO INC COM NEW ACET ACET 157,827 $1.4m0.63% 0.63% UnchangedShares held: Q3 2025 —, Q4 2025 157.8k, Q1 2026 157.8k, Q2 2026 157.8k

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
TERNS PHARMACEUTICALS INC 604,534 $31.9m604.5k shares
COMPASS THERAPEUTICS INC CMPX CMPX 848,204 $4.5m848.2k shares
OCULIS HOLDING AG OCS OCS 149,592 $4.0m149.6k shares
KALVISTA PHARMACEUTICALS INC KALV KALV 131,796 $2.7m131.8k shares
SUMMIT THERAPEUTICS INC SMMT SMMT 89,717 $1.7m89.7k shares